Skip to content

Clinical trials

Phase 1 Glucose Metabolism Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glucose Metabolism Disorders Phase: Phase 1 Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20103
20112
20121
20132
20151
20171
20191
20221
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer5
CRISPR Therapeutics AG2
Merck Sharp & Dohme LLC2
AstraZeneca1
Beta-Stim Ltd.1
Eli Lilly and Company1
Hanmi Pharmaceutical Company Limited1
Hvidovre University Hospital1
Johnny Ludvigsson1
Juan Pascual1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glucose Metabolism Disorders18
Diabetes Mellitus14
Diabetes Mellitus, Type 212
Metabolic Diseases12
Endocrine System Diseases9
Diabetes Mellitus, Type 13
Autoimmune Diseases2
Immune System Diseases2
Insulin Resistance2
Obesity2

Trials

Showing 76 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.